Position in INCY
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$370,120
New position
Shares Held
3,265
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#581
of 854 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Crestwood Advisors Group, LLC holds $9,188,630 across 10 Biotechnology names. INCY ranks #5 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,184 | $3,568,508 | |
| 2 | RARE |
Ultragenyx Pharmaceutical Inc.
|
100,274 | $3,348,148 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
743 | $463,290 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,561 | $376,154 | |
| 5 | INCY |
Incyte Corp
This page
|
3,265 | $370,120 | |
| 6 | MRNA |
Moderna, Inc.
|
4,608 | $322,698 | |
| 7 | CCCC |
C4 Therapeutics, Inc.
|
66,536 | $310,722 | |
| 8 | IBRX |
ImmunityBio, Inc.
|
34,410 | $301,259 |
All Filings in INCY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $370,120 | 3,265 | Shares | Sole | 2026-08-03 | |
| No filing history on record for this holder in this stock. | ||||||